Highly efficient delivery of a large therapeutic mass aerosol

Abstract

A method for delivering an agent to the pulmonary system, in a single, breath-activated step or a single breath, comprises administering from a receptacle enclosing a mass of particles, to a subject's respiratory tract, particles which have a tap density of less than 0.4 g/cm 3 and deliver at least about 50% of the mass of particles. The particles are capable of carrying agents. The agent is (1) part of the spray-drying pre-mixture and thereby incorporated into the particles, (2) added to separately-prepared particles so that the agent is in chemical association with the particles or (3) blended so that the agent is mixed with, and co-delivered with the particles. Respirable compositions comprising carrier particles having a tap density of less than 0.4 g/cm 3 and a composition comprising an agent are also disclosed. Methods of delivering these respirable compositions are also included.

1 - 151 . (canceled) 
     
     
         152 . A method of delivering an agent to the pulmonary system, in a single, breath-activated step, comprising administering particles comprising an agent from a receptacle having a mass consisting of said particles to a subject's respiratory tract, wherein:
 i) at least about 50% of the mass of particles stored in the receptacle is delivered to the lungs of the subject; and   ii) at least about 5 milligrams of the agent is delivered to the lungs of the subject.   
     
     
         153 . The method of  claim 152 , wherein the particles have a tap density of less than about 0.4 g/cm 3 . 
     
     
         154 . The method of  claim 152 , wherein the particles have a tap density of less than about 0.1 g/cm 3 . 
     
     
         155 . The method of  claim 153 , wherein delivery is primarily to the deep lung. 
     
     
         156 . The method of  claim 153 , wherein the particles are spray-dried particles. 
     
     
         157 . The method of  claim 156 , wherein the particles are in the form of a dry powder. 
     
     
         158 . The method of  claim 157 , wherein administration to the respiratory tract is by a dry powder inhaler. 
     
     
         159 . The method of  claim 158 , wherein the agent is non-crystalline. 
     
     
         160 . The method of  claim 158 , wherein at least 50% of the particles have a fine particle fraction less than 4.0 μm. 
     
     
         161 . The method of  claim 158 , wherein at least 75% of the particles have a fine particle fraction less than 6.8 μm.